Duke University

Running trials

• Not yet recruiting

  The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study

  NCT07216963· Duke University· Source

• Not yet recruiting

  A Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer

  NCT07905131· Phase 1/2· Daniel Nussbaum, M.D.· Source

• Not yet recruiting

  Addressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression

  NCT05459077· Duke University· Source

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· University of Michigan· Source

• Recruiting

  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  NCT07830732· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Lupus Nephritis Care Pathway

  NCT07783152· Duke University· Source

• Recruiting

  INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

  NCT06965504· Abiomed Inc.· Source

• Not yet recruiting

  Jigsawdio Multisensory Platform for People With Mild Cognitive Impairment, Alzheimer's Disease, or Related Dementias

  NCT07839286· Callahan-Young LLC DBA Jigsawdio· Source

• Not yet recruiting

  Signatera Assessment in Early-Stage Endometrial Cancer

  NCT07339384· Natera, Inc.· Source

• Not yet recruiting

  Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

  NCT07746271· Phase 3· The George Washington University Biostatistics Center· Source

• Recruiting

  A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis

  NCT07588568· Phase 2· University of North Carolina, Chapel Hill· Source

• Recruiting

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  NCT07648264· Phase 3· CSL Behring· Source

• Recruiting

  Cognitive Rehabilitation for Treatment of Anger in Veterans With TBI and PTSD

  NCT07227987· Duke University· Source

• Recruiting

  Asciminib in HER2+ Breast Cancer Brain Metastases

  NCT07136428· Phase 1/2· Duke University· Source

• Recruiting

  Project Q: Cue-based Treatment Intervention to Promote Cessation Among People Who Smoke Lightly or Non-daily

  NCT07425119· Duke University· Source

• Not yet recruiting

  Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

  NCT06596512· Brigham and Women's Hospital· Source

• Not yet recruiting

  Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)

  NCT07601295· Phase 2· Stanford University· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Prilenia· Source

• Not yet recruiting

  Virtual Activities of Living for Occupational Rehabilitation

  NCT07450586· Barron Associates, Inc.· Source

• Recruiting

  A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

  NCT07428616· Phase 2· Exelixis· Source

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

  NCT07226453· Phase 2· University of California, San Francisco· Source

• Not yet recruiting

  Occlutech AFR Fontan Study

  NCT07532369· Occlutech International AB· Source

• Recruiting

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· Phase 3· Inhibikase Therapeutics· Source

• Recruiting

  A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)

  NCT07282847· Phase 1/2· AskBio Inc· Source

• Recruiting

  SickleFit Exercise and Nutrition Study

  NCT07442851· Duke University· Source

• Recruiting

  Rural Smoking Cessation

  NCT06584929· Masonic Cancer Center, University of Minnesota· Source

• Recruiting

  Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

  NCT07144228· Duke University· Source

• Recruiting

  Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  NCT07421700· Phase 1/2· Pfizer· Source

• Recruiting

  A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

  NCT07491497· Phase 1/2· TRIANA Biomedicines, Inc.· Source

• Recruiting

  Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  NCT07477639· Phase 1/2· Tr1X, Inc.· Source

• Recruiting

  Using PrEP, Doing It for Ourselves

  NCT06638892· Duke University· Source

• Recruiting

  Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

  NCT07351071· Medtronic - MITG· Source

• Recruiting

  Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

  NCT07110454· Epiminder America, Inc.· Source

• Recruiting

  Diagnosing Epilepsy To EffeCT Change

  NCT07110337· Epiminder America, Inc.· Source

• Recruiting

  CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

  NCT07322094· Phase 1/2· TORL Biotherapeutics, LLC· Source

• Enrolling by invitation

  Dialysis Geriatric Care Model

  NCT05793138· Duke University· Source

• Recruiting

  Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

  NCT06816927· Phase 2· Duke University· Source

• Recruiting

  Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  NCT06906627· Duke University· Source

• Recruiting

  Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  NCT06906640· Duke University· Source

• Recruiting

  Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy

  NCT06986304· Duke University· Source

• Recruiting

  A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  NCT07221500· Phase 2· Nurix Therapeutics, Inc.· Source

• Recruiting

  Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

  NCT06795529· Massachusetts General Hospital· Source

• Recruiting

  This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  NCT07028853· Phase 3· Pfizer· Source

• Recruiting

  A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  NCT07115745· Phase 1· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Recruiting

  A Study of GNTI-122 in Adults Recently Diagnosed With T1D

  NCT06919354· Phase 1· GentiBio, Inc· Source

• Active, not recruiting

  Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

  NCT07120945· Medtronic - MITG· Source

• Enrolling by invitation

  Enhancing Resilience Among Patients With Stroke: Implementation of High Intensity Home-based Rehabilitation

  NCT07098286· Duke University· Source

• Active, not recruiting

  A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

  NCT06985147· Phase 2· Disc Medicine, Inc· Source

• Recruiting

  COMPASS Study for Metastatic Castration-resistant Prostate Cancer

  NCT07050433· Duke University· Source

Showing 50 of 229.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers12 recruiting
• Prostate cancer10 recruiting
• Heart failure9 recruiting
• Lung cancer8 recruiting
• High blood pressure6 recruiting
• Sarcoma6 recruiting
• Chronic lymphocytic leukaemia5 recruiting
• Coronary artery disease5 recruiting
• Glioblastoma5 recruiting
• Stroke5 recruiting
• Type 1 diabetes5 recruiting
• Acute myeloid leukaemia4 recruiting
• Colorectal cancer4 recruiting
• Epilepsy4 recruiting
• Lupus (SLE)4 recruiting
• Metastatic breast cancer4 recruiting
• Mild cognitive impairment4 recruiting
• Pulmonary arterial hypertension4 recruiting
• Rheumatoid arthritis4 recruiting
• Acute lymphoblastic leukaemia3 recruiting
• Alzheimer disease3 recruiting
• Brain metastases3 recruiting
• Chronic kidney disease3 recruiting
• Endometrial cancer3 recruiting
• Mantle cell lymphoma3 recruiting
• Neuroblastoma3 recruiting
• Ovarian cancer3 recruiting
• Systemic sclerosis (scleroderma)3 recruiting
• ALS (motor neurone disease)2 recruiting
• Aortic aneurysm2 recruiting
• Bladder cancer2 recruiting
• Follicular lymphoma2 recruiting
• Frontotemporal dementia2 recruiting
• Head and neck cancer2 recruiting
• HIV2 recruiting
• Huntington's disease2 recruiting
• Irritable bowel syndrome2 recruiting
• Liver and biliary tract cancer2 recruiting
• Multiple myeloma2 recruiting
• Multiple sclerosis2 recruiting
• Myasthenia gravis2 recruiting
• Myelodysplastic syndromes2 recruiting
• Osteoporosis2 recruiting
• Sickle cell disease2 recruiting
• Triple-negative breast cancer2 recruiting
• Type 2 diabetes2 recruiting
• Antiphospholipid syndrome1 recruiting
• Aortic stenosis1 recruiting
• Asthma1 recruiting
• Atrial fibrillation1 recruiting
• Autism1 recruiting
• Burkitt lymphoma1 recruiting
• Cervical cancer1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Congenital heart disease1 recruiting
• Depression1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Diabetic neuropathy1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Dystonia1 recruiting
• Eosinophilic oesophagitis1 recruiting
• Essential tremor1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Haemophilia1 recruiting
• Hidradenitis suppurativa1 recruiting
• Hodgkin lymphoma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Insomnia1 recruiting
• Melanoma1 recruiting
• Meningioma1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Obesity1 recruiting
• Obstructive sleep apnoea1 recruiting
• Pancreatic cancer1 recruiting
• Parkinson disease1 recruiting
• Polycystic ovary syndrome1 recruiting
• Pompe disease1 recruiting
• Sjögren's disease1 recruiting
• Spinal cord injury1 recruiting
• Thalassaemia1 recruiting
• Thyroid cancer1 recruiting
• Uterine fibroids1 recruiting

Closed trials

• Completed

  Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)

  NCT07089745· Duke University· Source

• Completed

  Assessing Better Bottles for Babies

  NCT06357299· Duke University· Source

• Completed

  Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE

  NCT06720584· Duke University· Source

• Completed

  Adapting and Piloting Behavioral Activation for Veterans With Alcohol Use Disorder and Posttraumatic Stress Disorder

  NCT06249386· RTI International· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Sharmila Dorbala· Source

• Completed

  Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

  NCT06576427· Jupiter Endovascular· Source

• Completed

  ABC-CT Pre-School Feasibility Study

  NCT06413316· Yale University· Source

• Terminated

  NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

  NCT06299163· Phase 1· Numab Therapeutics AG· Source

• Completed

  Ketones in Heart Failure With Reduced Ejection Fraction

  NCT06195982· Phase 2· Duke University· Source

• Completed

  Evaluation of Advanced Imaging and Visualization for Clinical Deep Brain Stimulation

  NCT06191874· Duke University· Source

• Completed

  TipTraQ Home Sleep Test Validation Study, Duke

  NCT06351878· PranaQ Pte. Ltd.· Source

• Recruiting

  A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  NCT06004245· Phase 1· Vividion Therapeutics, Inc.· Source

• Completed

  Healthy Lifestyles After Cancer for Adolescents and Young Adults: A Program to Reduce Cardiovascular Risk Factors

  NCT05869604· Duke University· Source

• Completed

  Accuracy Performance Verification of the INVOS™ System in Pediatrics

  NCT05962905· Medtronic - MITG· Source

• Completed

  Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer

  NCT06145750· Delfi Diagnostics Inc.· Source

• Terminated

  Visualization of the STN and GPi for DBS

  NCT05774041· Surgical Information Sciences Inc.· Source

• Completed

  El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham

  NCT05928182· Duke University· Source

• Completed

  A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

  NCT05975073· Phase 1/2· Amgen· Source

• Completed

  A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

  NCT05720702· Early phase 1· Duke University· Source

• Terminated

  64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

  NCT05633160· Phase 1/2· Clarity Pharmaceuticals Ltd· Source

• Completed

  Ketone Pharmacokinetic Study in HFrEF

  NCT05757193· Phase 1· Duke University· Source

• Completed

  Healthy Me: A Program for Older Women

  NCT03843190· Duke University· Source

• Completed

  Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

  NCT05783297· Amy K. Johnson, PhD, MSW· Source

• Completed

  AF at Home: A Virtual Education Program for Patients With Atrial Fibrillation (AF)

  NCT05810896· University of North Carolina, Chapel Hill· Source

• Completed

  A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

  NCT05686044· Phase 2/3· Annovis Bio Inc.· Source

• Completed

  Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study)

  NCT05714098· Duke University· Source

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts

  NCT05627011· Yale University· Source

• Terminated

  A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

  NCT05600426· Phase 3· Boston Children's Hospital· Source

• Terminated

  Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients

  NCT05068726· GE Healthcare· Source

• Completed

  Parks & Pediatrics Fit Together

  NCT05455190· Duke University· Source

• Completed

  Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

  NCT05602454· Duke University· Source

• Completed

  A Study of TAK-341 in Treatment of Multiple System Atrophy

  NCT05526391· Phase 2· Takeda· Source

• Completed

  Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

  NCT05643534· Phase 3· Ardelyx· Source

• Completed

  Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART

  NCT05604209· Phase 1· University of North Carolina, Chapel Hill· Source

• Completed

  Cognitive Disparities in Parkinson's Disease

  NCT07262658· Duke University· Source

• Completed

  Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO

  NCT05890274· University of North Carolina, Chapel Hill· Source

• Withdrawn

  ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures

  NCT05481905· Phase 2· Engrail Therapeutics INC· Source

• Recruiting

  Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

  NCT04839705· Microvention-Terumo, Inc.· Source

• Completed

  Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors

  NCT05383872· InSightec· Source

• Completed

  Motivating Occupational Virtual Experiences In Therapy for Kids

  NCT04510857· Barron Associates, Inc.· Source

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Biogen· Source

• Completed

  Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

  NCT05296473· Lumos Labs, Inc.· Source

• Completed

  Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

  NCT04972097· Angiodynamics, Inc.· Source

• Completed

  A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

  NCT04987489· Phase 2· Forma Therapeutics, Inc.· Source

• Withdrawn

  Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention

  NCT04826315· Duke University· Source

• Completed

  Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

  NCT04906447· Phase 2· University of Illinois Chicago· Source

• Completed

  A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

  NCT06734117· Hoffmann-La Roche· Source

• Terminated

  Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

  NCT04892446· Phase 2· Gilead Sciences· Source

• Completed

  Healthy Food First

  NCT05048836· University of North Carolina, Chapel Hill· Source

Showing 50 of 95.

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure327 works · 17 trials
• Stroke287 works · 13 trials
• HIV266 works · 7 trials
• Obesity244 works · 8 trials
• Alzheimer disease201 works · 9 trials
• Prostate cancer144 works · 14 trials
• Type 2 diabetes120 works · 3 trials
• Lung cancer118 works · 22 trials
• Glioblastoma90 works · 9 trials
• Atrial fibrillation88 works · 3 trials
• Chronic kidney disease86 works · 4 trials
• Melanoma82 works · 5 trials
• Deep vein thrombosis and pulmonary embolism71 works · 1 trial
• Colorectal cancer69 works · 6 trials
• Coronary artery disease67 works · 11 trials
• Epilepsy64 works · 9 trials
• Osteoarthritis64 works · 8 trials
• Parkinson disease62 works · 9 trials
• Glaucoma56 works · 0 trials
• Ovarian cancer55 works · 8 trials
• Sickle cell disease54 works · 10 trials
• Mild cognitive impairment46 works · 7 trials
• Sarcoma44 works · 11 trials
• Childhood cancers42 works · 17 trials
• Brain metastases40 works · 4 trials
• Tuberculosis39 works · 0 trials
• Osteoporosis36 works · 3 trials
• Congenital heart disease34 works · 4 trials
• Kidney cancer32 works · 4 trials
• Lupus (SLE)31 works · 6 trials